See also this year's filing and all EDGAR filings for this company.
PDF Report 0000849636_2015_Respirerx_Pharmaceuticals_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
| warning | Excluding company: variable exceeds outlier threshold | pre-agg | {'variable': 'Expenses', 'value': 6153855, 'size_variable': 'Assets', 'size_value': 145842, 'ratio': 42.2, 'threshold': 20} |
Graph
Absolute values for 0000849636, Respirerx Pharmaceuticals Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 320,673 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 16,741 |
| 3 | remainder_Assets | 62,894 |
| 4 | LiabilitiesCurrent | 2,600,708 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 3,823,434 |
| 9 | ResearchAndDevelopmentExpense | 591,768 |
| 10 | remainder_Expenses | 117,306 |
| 11 | remainder_Revenues | 61,667 |
| 12 | remainder_NetIncome | 1,763,306 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 400,308 |
| 1 | Liabilities | 2,600,708 |
| 2 | Expenses | 4,532,508 |
| 3 | Revenues | 61,667 |
| 4 | StockholdersEquity | -2,200,400 |
| 5 | NetIncome | -2,707,535 |
| 6 | ComprehensiveNetIncome | -2,707,535 |
| 7 | BaseVar | 4,679,248 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -5.00 |
| 9 | EconomicCapitalRatio | 0.191 |
Edgar->Model Mapping
Feature Distribution
Change over Time
